Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:1342-1344 (6 December), doi:10.1136/bmj.327.7427.1342
Peter A Singer, Sun Life financial chair and director1, Solomon R Benatar, visiting professor2, Mark Bernstein, professor3, Abdallah S Daar, director, programme in applied ethics and biotechnology1, Bernard M Dickens, Dr William M Scholl professor of health law and policy4, Susan K MacRae, deputy director1, Ross E G Upshur, director, primary care research unit5, Linda Wright, bioethicist1, Randi Zlotnik Shaul, bioethicist1
1 University of Toronto Joint Centre for Bioethics, 88 College St, Toronto, Canada M5G 1L4, 2 Department of Public Health Sciences, University of Toronto, 3 Division of Neurosurgery, University of Toronto, 4 Faculty of Law, University of Toronto, 5 Sunnybrook and Women's College Health Sciences Centre, Toronto
Correspondence to: P A Singer peter.singer@utoronto.ca
The SARS epidemic showed how easy it is for infectious diseases to spread round the world. Ethical as well as clinical issues need to be resolved to improve the response to the next epidemic
| The first 150 words of the full text of this article appear below. |
The outbreak of severe acute respiratory syndrome (SARS) in the Toronto area earlier this year forced medical and government workers to make hard choices, often with limited information and short deadlines. Healthcare providers were on the firing line, and were the people most affected by the disease.1 Decision makers had to balance individual freedoms against the common good, fear for personal safety against the duty to treat sick people, and economic losses against the need to contain the spread of a deadly disease. Such decisions have to be guided by both scientific knowledge and ethical considerations. The SARS outbreak showed that Canadian society was not fully prepared to deal with the ethical issues.
We formed a working group to identify the key ethical issues and values most important for an analysis of ethical dimensions of the SARS epidemic. The final list of issues and values was agreed by a consensus
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+